Rituximab-rixa (Rixathon)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 12:48, 26 May 2024 by Jwarner (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Note: this is a rituximab biosimilar. It was not granted FDA approval but is approved in Europe.

Also known as

  • Code name: GP-2013
  • Brand name: Rixathon